Literature DB >> 31829286

Effectiveness of an online self-management tool, OPERAS (an On-demand Program to EmpoweR Active Self-management), for people with rheumatoid arthritis: a research protocol.

Johnathan Tam1, Diane Lacaille1,2, Teresa Liu-Ambrose3, Chris Shaw4, Hui Xie1,5, Catherine L Backman1,6, John M Esdaile1,2, Kimberly Miller3,5,7, Robert Petrella8, Linda C Li9,10.   

Abstract

BACKGROUND: Active self-management is a process where patients are fully engaged in managing their health in daily life by having access to contextualized health data and tailored guidance to support a healthy lifestyle. This study aims to determine whether an e-health intervention that incorporates symptom/disease activity monitoring and physical activity counselling can improve self-management ability in patients with rheumatoid arthritis (RA).
METHODS: The 'Empowering active self-management of arthritis: Raising the bar with OPERAS (an On-demand Program to EmpoweR Active Self-management)' project is a randomized controlled trial that uses a delayed control design. One hundred thirty-four participants with RA will be randomly assigned to start the intervention either immediately (immediate group) or 6 months later (delayed group). The intervention involves (1) use of a Fitbit-compatible web app to record and monitor their RA disease activity, symptoms, and time spent on physical activity and a Fitbit; (2) group education and individual counselling by a physiotherapist (PT); and (3) six phone calls with a PT. The primary outcome measure is self-management ability measured by the Patient Activation Measure. Secondary outcome measures include disease status, fatigue, pain, depressive symptoms, and characteristics of habitual behavior and also time spent in physical activity and sedentary activity with a wearable multi-sensor device (SenseWear Mini). After the 6-month intervention, we will interview a sample of participants to examine their experiences with the intervention. DISCUSSION: The results of this study will help to determine whether this technology-enhanced self-management intervention improves self-management ability and health outcomes for people living with RA. A limitation of this study is that participants will need to self-report their symptoms, disease status, and treatment use through questionnaires on the OPERAS web app. The user-friendly interface, reminder emails from the research staff, and tailored guidance from PTs will encourage participants to actively engage with the app. TRIAL REGISTRATION: Date of last update in ClinicalTrials.gov: January 2, 2019. ClinicalTrials.gov Identifier: NCT03404245.

Entities:  

Keywords:  Physical activity; Rheumatoid arthritis; Self-management; Self-monitoring; e-health

Year:  2019        PMID: 31829286     DOI: 10.1186/s13063-019-3851-0

Source DB:  PubMed          Journal:  Trials        ISSN: 1745-6215            Impact factor:   2.279


  4 in total

1.  Understanding the Needs and Priorities of People Living with Persistent Pain and Long-Term Musculoskeletal Conditions during the COVID-19 Pandemic-A Public Involvement Project.

Authors:  Sally Fowler Davis; Helen Humphreys; Tom Maden-Wilkinson; Sarah Withers; Anna Lowe; Robert J Copeland
Journal:  Healthcare (Basel)       Date:  2022-06-17

2.  Experiences of self-care during the COVID-19 pandemic among individuals with rheumatoid arthritis: A qualitative study.

Authors:  Jenny Leese; Catherine L Backman; Jasmin K Ma; Cheryl Koehn; Alison M Hoens; Kelly English; Eileen Davidson; Shanon McQuitty; James Gavin; Jo Adams; Stephanie Therrien; Linda C Li
Journal:  Health Expect       Date:  2021-08-17       Impact factor: 3.318

Review 3.  Smartphones for musculoskeletal research - hype or hope? Lessons from a decennium of mHealth studies.

Authors:  Anna L Beukenhorst; Katie L Druce; Diederik De Cock
Journal:  BMC Musculoskelet Disord       Date:  2022-05-23       Impact factor: 2.562

Review 4.  Renegotiating dimensions of the self: A systematic review and qualitative evidence synthesis of the lived experience of self-managing rheumatoid arthritis.

Authors:  Susie Donnelly; Molly Manning; Hasheem Mannan; Anthony G Wilson; Thilo Kroll
Journal:  Health Expect       Date:  2020-09-01       Impact factor: 3.377

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.